What evidence would justify switching on AI prioritization of head CTs?

Instruction: Give a go/no-go plan for this deployment, including the reference assessment, unflagged cases, workflow measures, stopping criteria, and ownership of updates.

Context: A vendor proposes an AI tool that moves head CTs flagged for possible intracranial hemorrhage up this fictional hospital’s reporting queue. Its demonstration used selected positive cases. Your hospital has several scanner models, postsurgical patients, and clinically urgent studies that may contain no hemorrhage. The vendor can run the tool without changing the worklist during a pilot. Managers want immediate deployment.

Updated

Official answer available

Read the opening below, then unlock the full answer and practical guidance.

After governance, privacy, and data-access approval, I would start in observation mode, with no queue changes. The sales demonstration tells us little about missed hemorrhage, failed processing, or delays for patients whose urgency comes from something else. We need representative eligible examinations, the intended-use restrictions, and an independent reference assessment with a process for resolving uncertain cases...

Upgrade to view official answer

Related Questions